Mesa Verde Venture Partners

Mesa Verde Venture Partners operates as an early-stage life sciences venture capital firm. The company specializes in providing strategic capital and operational guidance to nascent enterprises focused on therapeutics, medical devices, diagnostics, and broader healthcare innovations. Their approach emphasizes close collaboration with founding teams to develop and scale breakthrough technologies within the biotechnology and medical technology landscapes.

Established in 2006, the firm's investment strategy is led by Managing Directors Carey Ng, PhD, MBA, Fred Middleton, MBA, and Francois Ferre, PhD. This leadership team brings diverse expertise across scientific research, business development, and financial management. Their collective insight identified a critical need for engaged, early-stage funding and mentorship for promising life science ventures, evolving from a legacy of prior successful ventures.

Mesa Verde Venture Partners primarily serves entrepreneurs and emerging companies within the life sciences sector, particularly those in the Southwest. The firm's long-term vision centers on fostering the growth of a diversified portfolio of innovative companies, ultimately contributing to advancements in human health by transforming scientific discoveries into viable commercial solutions through active partnership and support.